Soleno Therapeutics (SLNO) Payables (2013 - 2026)
Soleno Therapeutics (SLNO) reported Payables of $12.4 million for Q1 2026, up 125.9% year-over-year from $5.5 million in Q1 2025, and little changed on a QoQ basis from $12.4 million in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of Payables data on file, last reported at $12.4 million in Q1 2026.
- Quarterly Payables rose 125.9% year-over-year to $12.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (up 125.9% YoY) and the FY2025 annual result came in at $12.4 million, up 40.0% from the prior year.
- Payables was little changed at $12.4 million in Q1 2026 per SLNO's latest filing, from $12.4 million in the prior quarter.
- Across five years, Payables topped out at $12.4 million in Q4 2025 and bottomed at $1.8 million in Q4 2022.
- The 5-year median for Payables is $3.7 million (2024), against an average of $5.5 million.
- The widest annual swing landed in 2022, when Payables slumped 48.36%; it then jumped 188.77% in 2024.
- Tracing SLNO's Payables over 5 years: stood at $1.8 million in 2022, then jumped by 77.21% to $3.1 million in 2023, then surged by 182.06% to $8.9 million in 2024, then jumped by 40.0% to $12.4 million in 2025, then retreated by 0.39% to $12.4 million in 2026.
- Per Business Quant, the three latest SLNO Payables figures stand at $12.4 million (Q1 2026), $12.4 million (Q4 2025), and $8.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 12.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.39 Mn |
| Dec 31, 2025 | 12.44 Mn |
| Sep 30, 2025 | 8.15 Mn |
| Jun 30, 2025 | 6.22 Mn |
| Mar 31, 2025 | 5.48 Mn |
| Dec 31, 2024 | 8.88 Mn |
| Sep 30, 2024 | 6.24 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 8.02 Mn |
| Dec 31, 2023 | 3.15 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 3.44 Mn |
| Mar 31, 2023 | 2.78 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 2.32 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Mar 31, 2022 | 2.41 Mn |
| Dec 31, 2021 | 3.25 Mn |
| Sep 30, 2021 | 3.86 Mn |
| Jun 30, 2021 | 3.35 Mn |
| Mar 31, 2021 | 4.67 Mn |
| Dec 31, 2020 | 3.49 Mn |
| Sep 30, 2020 | 3.21 Mn |
| Jun 30, 2020 | 3.66 Mn |
| Mar 31, 2020 | 3.48 Mn |
| Dec 31, 2019 | 2.00 Mn |
| Sep 30, 2019 | 1.74 Mn |
| Jun 30, 2019 | 1.74 Mn |
| Mar 31, 2019 | 1.26 Mn |
| Dec 31, 2018 | 934,000.00 |
| Sep 30, 2018 | 1.25 Mn |
| Jun 30, 2018 | 981,000.00 |
| Mar 31, 2018 | 1.13 Mn |
| Dec 31, 2017 | 633,000.00 |
| Sep 30, 2017 | 642,000.00 |
| Jun 30, 2017 | 1.03 Mn |
| Mar 31, 2017 | 935,000.00 |
| Dec 31, 2016 | 410,512.00 |
| Sep 30, 2016 | 862,000.00 |
| Jun 30, 2016 | 957,000.00 |
| Mar 31, 2016 | 1.26 Mn |
| Dec 31, 2015 | 695,056.00 |
| Sep 30, 2015 | 953,000.00 |
| Jun 30, 2015 | 989,000.00 |
| Mar 31, 2015 | 621,000.00 |
| Dec 31, 2014 | 986,799.00 |
| Sep 30, 2014 | 1.24 Mn |
| Dec 31, 2013 | 57,721.00 |